Global Automated IV Compounding System Market Growth 2025-2031

The global Automated IV Compounding System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

An Automated IV Compounding System is a sophisticated medical technology designed for the precise and automated preparation of intravenous (IV) medications in healthcare settings. This system streamlines the compounding process by employing robotics and advanced software to measure, mix, and dispense medications with a high degree of accuracy. It minimizes the risk of human errors associated with manual compounding, ensuring the precise dosage and sterile preparation of IV medications. These systems typically feature safety mechanisms, such as barcode scanning and weight verification, to enhance accuracy and prevent medication errors. Automated IV compounding systems contribute to improved patient safety, efficiency, and consistency in medication preparation, particularly in critical care situations where precise dosage and sterility are paramount.

United States market for Automated IV Compounding System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Automated IV Compounding System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Automated IV Compounding System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Automated IV Compounding System players cover Arxium, Omnicell, Grifols, NewIcon, Comecer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Automated IV Compounding System Industry Forecast” looks at past sales and reviews total world Automated IV Compounding System sales in 2024, providing a comprehensive analysis by region and market sector of projected Automated IV Compounding System sales for 2025 through 2031. With Automated IV Compounding System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated IV Compounding System industry.

This Insight Report provides a comprehensive analysis of the global Automated IV Compounding System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automated IV Compounding System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automated IV Compounding System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated IV Compounding System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated IV Compounding System.

This report presents a comprehensive overview, market shares, and growth opportunities of Automated IV Compounding System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Vials Compatible
Syringes Compatible
IV Bags Compatible

Segmentation by Application:
Clinic
Hospital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Arxium
Omnicell
Grifols
NewIcon
Comecer
ICU Medical
Kapsam Health Products
Steriline
Baxter
Weibond Technology
Lachsis
Shenzhen Broadcare Robots
General Healthy

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated IV Compounding System market?

What factors are driving Automated IV Compounding System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated IV Compounding System market opportunities vary by end market size?

How does Automated IV Compounding System break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.